These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1113 related articles for article (PubMed ID: 19320557)
21. Prevalence of metabolic syndrome in Nakhon Sawan population. Santibhavank P J Med Assoc Thai; 2007 Jun; 90(6):1109-15. PubMed ID: 17624204 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305 [TBL] [Abstract][Full Text] [Related]
23. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of metabolic syndrome in Saudi adult soldiers. Al-Qahtani DA; Imtiaz ML Saudi Med J; 2005 Sep; 26(9):1360-6. PubMed ID: 16155648 [TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE; Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population. Császár A; Kékes E; Abel T; Papp R; Kiss I; Balogh S Blood Press; 2006; 15(2):101-6. PubMed ID: 16754273 [TBL] [Abstract][Full Text] [Related]
27. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. Mattsson N; Rönnemaa T; Juonala M; Viikari JS; Raitakari OT J Intern Med; 2007 Feb; 261(2):159-69. PubMed ID: 17241181 [TBL] [Abstract][Full Text] [Related]
29. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria. Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology of metabolic syndrome in Asia. Pan WH; Yeh WT; Weng LC Asia Pac J Clin Nutr; 2008; 17 Suppl 1():37-42. PubMed ID: 18296297 [TBL] [Abstract][Full Text] [Related]
32. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions. Nilsson PM; Engström G; Hedblad B Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496 [TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO. Ma WY; Li HY; Hung CS; Lin MS; Chiu FC; Lin CH; Shih SR; Chuang LM; Wei JN Diabetes Res Clin Pract; 2009 Sep; 85(3):335-41. PubMed ID: 19608293 [TBL] [Abstract][Full Text] [Related]
34. Measures of obesity and metabolic syndrome in Indian Americans in northern California. Misra KB; Endemann SW; Ayer M Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232 [TBL] [Abstract][Full Text] [Related]
35. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease. Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240 [TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study. Fiuza M; Cortez-Dias N; Martins S; Belo A; Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions. Bhattacharya SM Gynecol Endocrinol; 2010 Jul; 26(7):516-20. PubMed ID: 20540665 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people. Kim HM; Kim DJ; Jung IH; Park C; Park J Diabetes Res Clin Pract; 2007 Jul; 77(1):99-106. PubMed ID: 17118477 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Zabetian A; Hadaegh F; Azizi F Diabetes Res Clin Pract; 2007 Aug; 77(2):251-7. PubMed ID: 17234299 [TBL] [Abstract][Full Text] [Related]
40. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Assmann G; Guerra R; Fox G; Cullen P; Schulte H; Willett D; Grundy SM Am J Cardiol; 2007 Feb; 99(4):541-8. PubMed ID: 17293200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]